Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistNutrition Strength Ltd. was cited for marketing unapproved new animal drugs, specifically "Dog Seizure and Epilepsy Supplement" and "Blood Support for Dogs," in violation of the Federal Food, Drug, and Cosmetic Act. The FDA determined these products qualified as drugs based on their intended use for treating disease conditions and affecting body structure or function, as evidenced by disease-related claims on the company's website, product labeling, and linked Amazon sales pages. The compliance failures included making therapeutic claims indicating the products were intended to treat seizures, epilepsy, and other disease conditions without FDA approval as new animal drugs.